Trevigen,

On September 5, 2017 Bio-Techne proudly announced its acquisition of Trevigen, Inc. For over 25 years, Trevigen has developed innovative tools for generating and analyzing physiologic cell culture models, such as organoids, tumorspheres, and stem cell-derived cellular systems. These models are being used to make critical advancements in drug discovery, toxicology, regenerative medicine, cell therapy, and cancer research. With strong brands like the CultrexTM Basement Membrane Matrix and the CometAssayTM for cell damage, the Trevigen product portfolio is an important addition to Bio-Techne. It solidifies our ability to offer full workflow solutions to customers using 2D and 3D culture models to investigate cell behavior and cytotoxic events.